Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults.

Sun, Luanluan; Clarke, Robert; Bennett, Derrick; Guo, Yu; Walters, Robin G; Hill, Michael; Parish, Sarah; Millwood, Iona Y et al. · Nat Med · 2019

case_control · Level III

Where this comes from

Abstract

Stroke is the second leading cause of death worldwide and accounts for >2 million deaths annually in China<sup>1,2</sup>. Ischemic stroke (IS) and intracerebral hemorrhage (ICH) account for an equal number of deaths in China, despite a fourfold greater incidence of IS<sup>1,2</sup>. Stroke incidence and ICH proportion are higher in China than in Western populations<sup>3-5</sup>, despite having a lower mean low-density lipoprotein cholesterol (LDL-C) concentration. Observational studies reported weaker positive associations of LDL-C with IS than with coronary heart disease (CHD)<sup>6,7</sup>, but LDL-C-lowering trials demonstrated similar risk reductions for IS and CHD<sup>8-10</sup>. Mendelian randomization studies of LDL-C and IS have reported conflicting results<sup>11-13</sup>, and concerns about the excess risks of ICH associated with lowering LDL-C<sup>14,15</sup> may have prevented the more widespread use of statins in China. We examined the associations of biochemically measured lipids with stroke in a nested case-control study in the China Kadoorie Biobank (CKB) and compared the risks for both stroke types associated with equivalent differences in LDL-C in Mendelian randomization analyses. The results demonstrated positive associations of LDL-C with IS and equally strong inverse associations with ICH, which were confirmed by genetic analyses and LDL-C-lowering trials. Lowering LDL-C is still likely to have net benefit for the prevention of overall stroke and cardiovascular disease in China.

Medical subject headings